Maxcyte Inc (MXCT)

R&D Expenses

$4.25M

Quarterly · Period ending: · USD

MXCT logo

MXCT R&D Expenses

Latest reported$4.25M
MXCT Quarterly R&D Expenses ($609.35K → $4.25M)
High-resolution chart · PNG

MXCT r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Maxcyte Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
4,253,000
3,857,000
3,335,000
5,316,000
6,269,000
5,903,000
4,614,000
5,316,000
5,619,000
6,678,000
5,842,100
6,264,000
5,664,000
6,047,000
5,728,000
5,325,100
4,696,000
3,765,300
3,381,000
2,746,900
3,203,900
6,076,300
4,891,500
4,517,900
4,090,400
4,244,700
3,944,200
3,953,100
4,847,500
4,847,500
3,165,650
3,165,650
2,456,350
2,456,350
3,546,100
3,546,100
2,096,299
2,096,299
1,321,750
1,321,750
1,026,450
1,026,450
784,200
784,200
719,850
719,850
635,750
635,750
609,350
609,350
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.